Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing-Reference-Cited by-同舟云学术

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing

Published:2022-11 Issue:11 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

López‐Cánovas Juan L.¹²³⁴,Hermán‐Sánchez Natalia¹²³⁴,Moreno‐Montilla Maria Trinidad¹²³⁴,del Rio‐Moreno Mercedes¹²³⁴,Alors‐Perez Emilia¹²³⁴,Sánchez‐Frias Marina E.¹³,Amado Víctor¹⁵⁶,Ciria Rubén¹⁷,Briceño Javier¹⁷,de la Mata Manuel¹⁵⁶,Castaño Justo P.¹²³⁴,Rodriguez‐Perálvarez Manuel¹⁵⁶,Luque Raúl M.¹²³⁴,Gahete Manuel D.¹²³⁴^ORCID

Affiliation:

1. Maimonides Biomedical Research Institute of Cordoba (IMIBIC) Cordoba Spain

2. Department of Cell Biology Physiology and Immunology University of Córdoba Cordoba Spain

3. Reina Sofía University Hospital Cordoba Spain

4. CIBER Pathophysiology of Obesity and Nutrition (CIBERobn) Cordoba Spain

5. Department of Hepatology and Liver Transplantation Reina Sofía University Hospital Cordoba Spain

6. CIBER Hepatic and Digestive Diseases (CIBERehd) Cordoba Spain

7. Unit of Hepatobiliary Surgery and Liver Transplantation University Hospital Reina Sofia Cordoba Spain

Funder

Instituto de Salud Carlos III

European Commission

Ministerio de Ciencia e Innovación